Susquehanna International Group
AVXL icon

Susquehanna International Group’s Anavex Life Sciences AVXL Stock Holding History

Susquehanna International Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$735K Sell
239,500
-337,200
-58% -$1.46M ﹤0.01% 8688
2025
Q4 		$2.05M Sell
576,700
-16,900
-3% -$104K ﹤0.01% 5609
2025
Q3 		$5.28M Buy
593,600
+352,800
+147% +$3.58M ﹤0.01% 4000
2025
Q2 		$2.22M Buy
240,800
+52,000
+28% +$444K ﹤0.01% 5577
2025
Q1 		$1.62M Sell
188,800
-24,800
-12% -$234K ﹤0.01% 6020
2024
Q4 		$2.29M Buy
213,600
+19,800
+10% +$152K ﹤0.01% 4995
2024
Q3 		$1.1M Sell
193,800
-75,400
-28% -$435K ﹤0.01% 6569
2024
Q2 		$1.14M Sell
269,200
-80,100
-23% -$324K ﹤0.01% 6291
2024
Q1 		$1.78M Buy
349,300
+57,300
+20% +$323K ﹤0.01% 5615
2023
Q4 		$2.72M Sell
292,000
-301,700
-51% -$2.08M ﹤0.01% 4744
2023
Q3 		$3.89M Buy
593,700
+261,900
+79% +$2.08M ﹤0.01% 3954
2023
Q2 		$2.7M Sell
331,800
-332,200
-50% -$2.85M ﹤0.01% 4557
2023
Q1 		$5.69M Buy
664,000
+203,300
+44% +$2.03M ﹤0.01% 3265
2022
Q4 		$4.27M Sell
460,700
-60,100
-12% -$642K ﹤0.01% 3479
2022
Q3 		$5.38M Buy
520,800
+48,700
+10% +$514K ﹤0.01% 3041
2022
Q2 		$4.73M Sell
472,100
-131,700
-22% -$1.25M ﹤0.01% 3274
2022
Q1 		$7.43M Buy
603,800
+250,700
+71% +$3.08M ﹤0.01% 2973
2021
Q4 		$6.12M Buy
353,100
+157,000
+80% +$2.98M ﹤0.01% 3418
2021
Q3 		$3.52M Sell
196,100
-144,200
-42% -$2.87M ﹤0.01% 4614
2021
Q2 		$7.78M Sell
340,300
-195,200
-36% -$2.89M ﹤0.01% 3291
2021
Q1 		$8.01M Buy
535,500
+385,100
+256% +$4.21M ﹤0.01% 3141
2020
Q4 		$812K Buy
150,400
+82,200
+121% +$433K ﹤0.01% 7194
2020
Q3 		$310K Buy
+68,200
New +$294K ﹤0.01% 8630
2020
Q1 		– Sell
-64,200
Closed -$166K – 10203
2019
Q4 		$166K Sell
64,200
-26,900
-30% -$70.6K ﹤0.01% 8883
2019
Q3 		$288K Buy
91,100
+48,200
+112% +$139K ﹤0.01% 8378
2019
Q2 		$145K Buy
+42,900
New +$133K ﹤0.01% 9395
2019
Q1 		– Sell
-10,900
Closed -$17K – 8797
2018
Q4 		$17K Sell
10,900
-40,300
-79% -$91.5K ﹤0.01% 8697
2018
Q3 		$140K Buy
51,200
+39,600
+341% +$112K ﹤0.01% 8452
2018
Q2 		$30K Sell
11,600
-3,900
-25% -$10.9K ﹤0.01% 9372
2018
Q1 		$43K Buy
+15,500
New +$43.8K ﹤0.01% 8994
2017
Q4 		– Sell
-27,700
Closed -$115K – 9216
2017
Q3 		$115K Sell
27,700
-16,000
-37% -$71.1K ﹤0.01% 8308
2017
Q2 		$232K Buy
43,700
+8,500
+24% +$49.1K ﹤0.01% 8035
2017
Q1 		$202K Buy
35,200
+18,700
+113% +$96.6K ﹤0.01% 7990
2016
Q4 		$65K Sell
16,500
-19,300
-54% -$68.8K ﹤0.01% 9221
2016
Q3 		$130K Sell
35,800
-51,100
-59% -$215K ﹤0.01% 7834
2016
Q2 		$531K Buy
86,900
+48,300
+125% +$233K ﹤0.01% 6010
2016
Q1 		$189K Sell
38,600
-169,700
-81% -$746K ﹤0.01% 8016
2015
Q4 		$1.16M Buy
+208,300
New +$1.48M ﹤0.01% 5115

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Susquehanna International Group's AVXL Position: Q1 2026 in Review

Susquehanna International Group increased its Anavex Life Sciences (AVXL) stake by 127% in Q1 2026, buying an estimated $2.41M and bringing the position to 995,663 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #5235.

Susquehanna International Group first reported a position in AVXL in Q4 2015 and has held it in 42 quarters since. The position peaked at $15.7M in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Susquehanna International Group held 995,663 shares of Anavex Life Sciences worth $3.06M as of Q1 2026.
  • Susquehanna International Group bought 556,164 Anavex Life Sciences shares in Q1 2026, an estimated $2.41M.
  • Anavex Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5235 holding.
  • Susquehanna International Group first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 42 quarters since.
  • Susquehanna International Group's Anavex Life Sciences position peaked at $15.7M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.